Irreversible electroporation facilitates gene transfer of a GM-CSF plasmid with a local and systemic response

Surgery (United States)

Volumn 154, Issue 3, 2013, Pages 496-503

  Au, Joyce T ^a   Mittra, Arjun ^a   Song, Tae Jin ^a,b   Cavnar, Michael ^a   Jun, Kyonghwa ^a,c   Carson, Joshua ^a   Gholami, Sepideh ^a   Haddad, Dana ^a   Gaujoux, Sebastien ^a   Monette, Sebastien ^a   Ezell, Paula ^a   Wolchok, Jedd ^a   Fong, Yuman ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b The Catholic University of Korea   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLASMID VECTOR;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; ELECTROPORATION; EXPERIMENTAL PIG; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IRREVERSIBLE ELECTROPORATION; LAPAROTOMY; LIVER LEVEL; LYMPH NODE; MACROPHAGE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE LEVEL;

ANIMALS; ELECTROPORATION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; NEOPLASMS; PLASMIDS; SWINE;

EID: 84883228585     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.06.005     Document Type: Article

References (27)

1. Y. Fong, J. Fortner, R.L. Sun, M.F. Brennan, and L.H. Blumgart Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 1999 309 318
2. Y. Fong, R.L. Sun, W. Jarnagin, and L.H. Blumgart An analysis of 412 cases of hepatocellular carcinoma at a Western center Ann Surg 229 1999 790 799
3. L.C. Heller, K. Ugen, and R. Heller Electroporation for targeted gene transfer Expert Opin Drug Deliv 2 2005 255 268
4. T. Tamura, and T. Sakata Application of in vivo electroporation to cancer gene therapy Curr Gene Ther 3 2003 59 64
5. Y.I. Yamashita, M. Shimada, H. Hasegawa, R. Minagawa, T. Rikimaru, and T. Hamatsu Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model Cancer Res 61 2001 1005 1012
6. A.I. Daud, R.C. DeConti, S. Andrews, P. Urbas, A.I. Riker, and V.K. Sondak Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma J Clin Oncol 26 2008 5896 5903
7. H.M. Horton, P.A. Lalor, and A.P. Rolland IL-2 plasmid electroporation: from preclinical studies to phase I clinical trial Methods Mol Biol 423 2008 361 372
8. L.C. Heller, and R. Heller Electroporation gene therapy preclinical and clinical trials for melanoma Curr Gene Ther 10 2010 312 317
9. K.P. Charpentier, F. Wolf, L. Noble, B. Winn, M. Resnick, and D.E. Dupuy Irreversible electroporation of the pancreas in swine: a pilot study HPB (Oxford) 12 2010 348 351
10. E.W. Lee, C. Chen, V.E. Prieto, S.M. Dry, C.T. Loh, and S.T. Kee Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation Radiology 255 2010 426 433
11. G. Onik, P. Mikus, and B. Rubinsky Irreversible electroporation: implications for prostate ablation Technol Cancer Res Treat 6 2007 295 300
12. B. Rubinsky, G. Onik, and P. Mikus Irreversible electroporation: a new ablation modality: clinical implications Technol Cancer Res Treat 6 2007 37 48
13. B. Al-Sakere, F. Andre, C. Bernat, E. Connault, P. Opolon, and R.V. Davalos Tumor ablation with irreversible electroporation PLoS One 2 2007 e1135
14. Y. Guo, Y. Zhang, R. Klein, G.M. Nijm, A.V. Sahakian, and R.A. Omary Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma Cancer Res 70 2010 1555 1563
15. R.E. Neal 2nd, R. Singh, H.C. Hatcher, N.D. Kock, S.V. Torti, and R.V. Davalos Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode Breast Cancer Res Treat 123 2010 295 301
16. T.P. Kingham, A.M. Karkar, M.I. D'Angelica, P.J. Allen, R.P. Dematteo, and G.I. Getrajdman Ablation of perivascular hepatic malignant tumors with irreversible electroporation J Am Coll Surg 215 2012 379 387
17. R.C. Martin 2nd, K. McFarland, S. Ellis, and V. Velanovich Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma J Am Coll Surg 215 2012 361 369
18. J.T. Au, J. Wong, A. Mittra, S. Carpenter, D. Haddad, and J. Carson Irreversible electroporation is a surgical ablation technique that enhances gene transfer Surgery 150 2011 474 479
19. M.A. Perales, J. Yuan, S. Powel, H.F. Gallardo, T.S. Rasalan, and C. Gonzalez Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma Mol Ther 16 2008 2022 2029
20. S. Inumaru, and H. Takamatsu cDNA cloning of porcine granulocyte- macrophage colony-stimulating factor Immunol Cell Biol 73 1995 474 476
21. K.A. Delman, J.S. Zager, J.J. Bennett, S. Malhotra, M.I. Ebright, and P.F. McAuliffe Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer Ann Surg 236 2002 337 342
22. H.M. Karpoff, M. D'Angelica, S. Blair, M.D. Brownlee, H. Federoff, and Y. Fong Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon J Clin Invest 99 1997 799 804
23. S. Malhotra, T. Kim, J. Zager, J. Bennett, M. Ebright, and M. D'Angelica Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas Surgery 141 2007 520 529
24. S.F. Alino, M.J. Herrero, I. Noguera, F. Dasi, and M. Sanchez Pig liver gene therapy by noninvasive interventionist catheterism Gene Ther 14 2007 334 343
25. J.W. Fabre, A. Grehan, M. Whitehorne, G.J. Sawyer, X. Dong, and S. Salehi Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava Gene Ther 15 2008 452 462
26. C.T. Moonen Spatio-temporal control of gene expression and cancer treatment using magnetic resonance imaging-guided focused ultrasound Clin Cancer Res 13 2007 3482 3489
27. K. Saito, K. Araki, N. Reddy, W. Guang, B.W. O'Malley Jr., and D. Li Enhanced local dendritic cell activity and tumor-specific immunoresponse in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model Head Neck 33 2011 359 367